about
Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disordersEfficacy and tolerability of the association of sibutramine and orlistat for six months in overweight and obese patientsObesity, diabetes, adiponectin and the kidney: a podocyte affair.Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?Human sports drug testing by mass spectrometry.Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.[Recent progress and novel perspectives on obesity pharmacotherapy].
P2860
Q27008813-45B8FFA1-11B9-44FF-9FDD-75F17FA49AAAQ34143583-52766739-3912-4F6E-9305-640D3EED0ED7Q37273056-68BFEDB7-3484-458B-82BC-EF4F556B6A1AQ37831334-D8F68ABF-7362-4EA5-B13B-ACEB83508B45Q38554891-3CB45440-8BA4-450C-8C07-8EE8FE712DF6Q38818675-5E9F0199-4358-41E9-ACF6-7B867C7A5ED1Q42881681-308391A0-4E5D-464A-9AD5-7E98E1796C6B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Investigational therapies in the treatment of obesity.
@ast
Investigational therapies in the treatment of obesity.
@en
type
label
Investigational therapies in the treatment of obesity.
@ast
Investigational therapies in the treatment of obesity.
@en
prefLabel
Investigational therapies in the treatment of obesity.
@ast
Investigational therapies in the treatment of obesity.
@en
P2860
P1476
Investigational therapies in the treatment of obesity.
@en
P2093
Alfredo Halpern
Marcio C Mancini
P2860
P304
P356
10.1517/13543784.15.8.897
P407
P577
2006-08-01T00:00:00Z